FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3189003616> ?p ?o ?g. }

• W3189003616 abstract "Mutations of calreticulin (CALR) are the second most prevalent driver mutations in essential thrombocythemia and primary myelofibrosis. To identify potential targeted therapies for CALR mutated myeloproliferative neoplasms, we searched for small molecules that selectively inhibit the growth of CALR mutated cells using high-throughput drug screening. We investigated 89 172 compounds using isogenic cell lines carrying CALR mutations and identified synthetic lethality with compounds targeting the ATR-CHK1 pathway. The selective inhibitory effect of these compounds was validated in a co-culture assay of CALR mutated and wild-type cells. Of the tested compounds, CHK1 inhibitors potently depleted CALR mutated cells, allowing wild-type cell dominance in the co-culture over time. Neither CALR deficient cells nor JAK2V617F mutated cells showed hypersensitivity to ATR-CHK1 inhibition, thus suggesting specificity for the oncogenic activation by the mutant CALR. CHK1 inhibitors induced replication stress in CALR mutated cells revealed by elevated pan-nuclear staining for γH2AX and hyperphosphorylation of RPA2. This was accompanied by S-phase cell cycle arrest due to incomplete DNA replication. Transcriptomic and phosphoproteomic analyses revealed a replication stress signature caused by oncogenic CALR, suggesting an intrinsic vulnerability to CHK1 perturbation. This study reveals the ATR-CHK1 pathway as a potential therapeutic target in CALR mutated hematopoietic cells." @default.
• W3189003616 created "2021-08-16" @default.
• W3189003616 creator A5007091163 @default.
• W3189003616 creator A5020900292 @default.
• W3189003616 creator A5025999782 @default.
• W3189003616 creator A5031531338 @default.
• W3189003616 creator A5036336178 @default.
• W3189003616 creator A5059183480 @default.
• W3189003616 creator A5062651582 @default.
• W3189003616 creator A5065115714 @default.
• W3189003616 creator A5079891848 @default.
• W3189003616 creator A5084485181 @default.
• W3189003616 creator A5091555194 @default.
• W3189003616 date "2021-07-31" @default.
• W3189003616 modified "2023-10-14" @default.
• W3189003616 title "High-throughput drug screening identifies the ATR-CHK1 pathway as a therapeutic vulnerability of CALR mutated hematopoietic cells" @default.
• W3189003616 cites W1980568348 @default.
• W3189003616 cites W1991001144 @default.
• W3189003616 cites W2010160165 @default.
• W3189003616 cites W2015946135 @default.
• W3189003616 cites W2028334384 @default.
• W3189003616 cites W2028616046 @default.
• W3189003616 cites W2049145190 @default.
• W3189003616 cites W2056777053 @default.
• W3189003616 cites W2057130382 @default.
• W3189003616 cites W2057360098 @default.
• W3189003616 cites W2065434335 @default.
• W3189003616 cites W2066663722 @default.
• W3189003616 cites W2070050178 @default.
• W3189003616 cites W2090885521 @default.
• W3189003616 cites W2102815568 @default.
• W3189003616 cites W2109637301 @default.
• W3189003616 cites W2115351357 @default.
• W3189003616 cites W2116878961 @default.
• W3189003616 cites W2117015521 @default.
• W3189003616 cites W2121743767 @default.
• W3189003616 cites W2122395736 @default.
• W3189003616 cites W2132399579 @default.
• W3189003616 cites W2138709799 @default.
• W3189003616 cites W2144664431 @default.
• W3189003616 cites W2157694607 @default.
• W3189003616 cites W2160738354 @default.
• W3189003616 cites W2173500616 @default.
• W3189003616 cites W2230798701 @default.
• W3189003616 cites W2278646061 @default.
• W3189003616 cites W2306779733 @default.
• W3189003616 cites W2344384041 @default.
• W3189003616 cites W2345356016 @default.
• W3189003616 cites W2417685891 @default.
• W3189003616 cites W2531346627 @default.
• W3189003616 cites W2561436545 @default.
• W3189003616 cites W2765195183 @default.
• W3189003616 cites W2766300480 @default.
• W3189003616 cites W2797725119 @default.
• W3189003616 cites W2887150799 @default.
• W3189003616 cites W2899760200 @default.
• W3189003616 cites W2921303898 @default.
• W3189003616 cites W2948635289 @default.
• W3189003616 cites W2954384525 @default.
• W3189003616 cites W3099651974 @default.
• W3189003616 cites W3145969289 @default.
• W3189003616 cites W3154101159 @default.
• W3189003616 cites W4245086829 @default.
• W3189003616 doi "https://doi.org/10.1038/s41408-021-00531-2" @default.
• W3189003616 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8325683" @default.
• W3189003616 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34333533" @default.
• W3189003616 hasPublicationYear "2021" @default.
• W3189003616 type Work @default.
• W3189003616 sameAs 3189003616 @default.
• W3189003616 citedByCount "1" @default.
• W3189003616 countsByYear W31890036162022 @default.
• W3189003616 crossrefType "journal-article" @default.
• W3189003616 hasAuthorship W3189003616A5007091163 @default.
• W3189003616 hasAuthorship W3189003616A5020900292 @default.
• W3189003616 hasAuthorship W3189003616A5025999782 @default.
• W3189003616 hasAuthorship W3189003616A5031531338 @default.
• W3189003616 hasAuthorship W3189003616A5036336178 @default.
• W3189003616 hasAuthorship W3189003616A5059183480 @default.
• W3189003616 hasAuthorship W3189003616A5062651582 @default.
• W3189003616 hasAuthorship W3189003616A5065115714 @default.
• W3189003616 hasAuthorship W3189003616A5079891848 @default.
• W3189003616 hasAuthorship W3189003616A5084485181 @default.
• W3189003616 hasAuthorship W3189003616A5091555194 @default.
• W3189003616 hasBestOaLocation W31890036161 @default.
• W3189003616 hasConcept C104317684 @default.
• W3189003616 hasConcept C109159458 @default.
• W3189003616 hasConcept C134935766 @default.
• W3189003616 hasConcept C153911025 @default.
• W3189003616 hasConcept C158617107 @default.
• W3189003616 hasConcept C2778502085 @default.
• W3189003616 hasConcept C28328180 @default.
• W3189003616 hasConcept C47450691 @default.
• W3189003616 hasConcept C502942594 @default.
• W3189003616 hasConcept C54355233 @default.
• W3189003616 hasConcept C86803240 @default.
• W3189003616 hasConceptScore W3189003616C104317684 @default.
• W3189003616 hasConceptScore W3189003616C109159458 @default.
• W3189003616 hasConceptScore W3189003616C134935766 @default.
• W3189003616 hasConceptScore W3189003616C153911025 @default.
• W3189003616 hasConceptScore W3189003616C158617107 @default.

• next